Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RimAsia Capital Partners is a private equity firm that focuses on mid-market investments across the Asia-Pacific region, with a significant emphasis on the healthcare and life sciences sectors. The firm specializes in buyouts, growth capital, and restructuring opportunities, often targeting companies that provide essential healthcare services, medical devices, or pharmaceutical distribution. RimAsia's investment strategy involves partnering with management teams to drive operational improvements and regional expansion. Notable healthcare-related investments in their history include stakes in hospital groups, renal care providers, and specialized medical service companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RimAsia.